Blocking enzyme ACSS2 is a potential way to treat triple-negative #breastcancer, found Komen grantee Dr. Zachary Schug. Read more: https://t.co/PVXi6ocTRK
Cool strategy to target lipid biosynthesis in TNBC. https://t.co/Hp5DW21tKT
Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth https://t.co/ciXDwTGyWJ
Finally got a chance to read this one!! Several several good bits of science. Awesome work by Kate, @SchugLab and team!!! Congratulations!!
Congrats @SchugLab. A great small molecule inhibitor to get into the clinic to inhibit ACSS2 #LMCforLife
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @FrezzaLab: Congrats to the @SchugLab !! Well done Zach Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @FrezzaLab: Congrats to the @SchugLab !! Well done Zach Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth https://t.co/UGFRSGqrHS
Congrats to the @SchugLab !! Well done Zach Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth https://t.co/Zj2dLfZ8sp
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
RT @CR_AACR: Read the article here: https://t.co/cWsmv9Wy6s https://t.co/WqEE8sAxR6
RT @CR_AACR: Read the article here: https://t.co/cWsmv9Wy6s
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
Read the article here: https://t.co/cWsmv9Wy6s
RT @mkatelyndyan: 1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to i…
1/n Excited to share the first, first author paper of my postdoc! Targeting of ACSS2 with a transition state mimetic to inhibit triple negative breast cancer growth. A thread. @Schuglab @TheWistar #ACSS2 #Acetate #Metabolism #CancerResearch https://t.co/a